Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia?

Lahti AC, Reid MA.

Neuropsychopharmacology. 2011 Aug;36(9):1779-80. doi: 10.1038/npp.2011.83. No abstract available.

2.

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.

de la Fuente-Sandoval C, León-Ortiz P, Favila R, Stephano S, Mamo D, Ramírez-Bermúdez J, Graff-Guerrero A.

Neuropsychopharmacology. 2011 Aug;36(9):1781-91. doi: 10.1038/npp.2011.65. Epub 2011 Apr 20.

3.

High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia.

Bustillo JR, Rowland LM, Lauriello J, Petropoulos H, Hammond R, Hart B, Brooks WM.

Am J Psychiatry. 2002 Jan;159(1):130-3.

PMID:
11772701
4.

MRI in tardive dyskinesia: shortened left caudate T2.

Bartzokis G, Garber HJ, Marder SR, Olendorf WH.

Biol Psychiatry. 1990 Dec 15;28(12):1027-36.

PMID:
1981152
5.

Electron microscopy of oligodendroglia in severe mental illness.

Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V.

Brain Res Bull. 2001 Jul 15;55(5):597-610.

PMID:
11576756
6.

The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics.

Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS.

Neuropsychopharmacology. 2001 Jan;24(1):47-54.

7.

Changes in caudate volume with neuroleptic treatment.

Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW.

Lancet. 1994 Nov 19;344(8934):1434. No abstract available.

PMID:
7968091
8.

Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia.

Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP.

J Neural Transm Suppl. 2007;(72):281-5.

PMID:
17982904
9.

Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients.

Uranova NA, Casanova MF, DeVaughn NM, Orlovskaya DD, Denisov DV.

Schizophr Res. 1996 Oct 18;22(1):81-3. No abstract available.

PMID:
8908694
10.

Reduced white matter volume of the caudate nucleus in patients with schizophrenia.

Takase K, Tamagaki C, Okugawa G, Nobuhara K, Minami T, Sugimoto T, Sawada S, Kinoshita T.

Neuropsychobiology. 2004;50(4):296-300.

PMID:
15539860
11.

Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.

Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baaré WF.

Psychiatry Res. 2007 Apr 15;154(3):199-208. Epub 2007 Mar 13.

PMID:
17360162
12.

Structural neuroimaging of the basal ganglia in schizophrenic patients: a review.

Brandt GN, Bonelli RM.

Wien Med Wochenschr. 2008;158(3-4):84-90. doi: 10.1007/s10354-007-0478-7. Review.

PMID:
18330524
13.

Comment regarding increased striatal glutamate in schizophrenia.

Maddock RJ, Buonocore MH.

Neuropsychopharmacology. 2012 Mar;37(4):1067-8; author reply 1069. doi: 10.1038/npp.2011.180. No abstract available.

14.

Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia.

Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, González-Blanch C, Pérez-Iglesias R, Gutiérrez A, de Lucas EM, Tordesillas D, Vázquez-Barquero JL.

Schizophr Res. 2007 Mar;91(1-3):87-96. Epub 2007 Feb 15.

PMID:
17306506
15.

[Schizophrenia: a psychobiological view].

Rodríguez-Arias M, Aguilar MA, Espert R, Miñarro J.

Rev Neurol. 1996 Oct;24(134):1210-20. Review. Spanish.

PMID:
8983716
16.

Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.

Emsley R, Asmal L, du Plessis S, Chiliza B, Kidd M, Carr J, Vink M.

Schizophr Res. 2015 Dec;169(1-3):89-94. doi: 10.1016/j.schres.2015.09.014. Epub 2015 Oct 4.

PMID:
26441006
17.

Mitochondria in the striatum of subjects with schizophrenia.

Somerville SM, Conley RR, Roberts RC.

World J Biol Psychiatry. 2011 Feb;12(1):48-56. doi: 10.3109/15622975.2010.505662. Epub 2010 Aug 10.

PMID:
20698738
18.

Association between striatal reduction and poor Wisconsin card sorting test performance in patients with schizophrenia.

Stratta P, Mancini F, Mattei P, Daneluzzo E, Casacchia M, Rossi A.

Biol Psychiatry. 1997 Nov 1;42(9):816-20.

PMID:
9347130
19.

CNS 14-3-3zeta: changes with sex but not psychiatric diagnoses or psychotropic drug treatment.

Dean B, Boer SA, Mackinnon A, Berk M.

Schizophr Res. 2007 Jul;93(1-3):51-7. Epub 2007 Mar 30.

PMID:
17399951
20.

Caudate and putamen volumes in good and poor outcome patients with schizophrenia.

Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K.

Schizophr Res. 2003 Nov 1;64(1):53-62.

PMID:
14511801

Supplemental Content

Support Center